Cargando…

Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis

Objective: To investigate the effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving intravenous alteplase thrombolysis. Methods: Patients with acute ischemic stroke who received intravenous alteplase thrombolysis between January 2016 and Decembe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pan, Yi, Xingyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540570/ https://www.ncbi.nlm.nih.gov/pubmed/37771034 http://dx.doi.org/10.1177/03946320231204597

Ejemplares similares

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Correlation Between Blood Glucose Variability and Early Therapeutic Effects After Intravenous Thrombolysis With Alteplase and Levels of Serum Inflammatory Factors in Patients With Acute Ischemic Stroke
por: Cai, Yun, et al.
Publicado: (2022)

Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Correction: Early neurological deterioration in acute ischemic stroke patients after intravenous thrombolysis with alteplase predicts poor 3-month functional prognosis - data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Che, Fengli, et al.
Publicado: (2022)

Blood pressure excursion on admission and intravenous thrombolysis in ischemic stroke
por: Du, Linzhe, et al.
Publicado: (2023)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Improving Neurological Function: A Multicenter, Cluster-Randomized Trial (GIANT)
por: Zhang, Xuting, et al.
Publicado: (2021)

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
por: Okada, Takashi, et al.
Publicado: (2022)

Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Toh, Emma M. S., et al.
Publicado: (2022)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
por: Chalos, Vicky, et al.
Publicado: (2019)

Clinical significance of stroke nurse in patients with acute ischemic stroke receiving intravenous thrombolysis
por: Xu, Zhao-Han, et al.
Publicado: (2021)

Blood glucose level affects prognosis of patients who received intravenous thrombolysis after acute ischemic stroke? A meta-analysis
por: Wang, Yue, et al.
Publicado: (2023)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis
por: Estella, A, et al.
Publicado: (2008)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Efficacy and safety of intravenous thrombolysis with alteplase for treating acute ischemic stroke at different time windows: A protocol for systematic review and meta-analysis
por: Huang, Baogang, et al.
Publicado: (2020)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke
por: Li, Hongfei, et al.
Publicado: (2022)

Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry
por: Sadeghi-Hokmabadi, Elyar, et al.
Publicado: (2021)

Admission Random Blood Glucose, Fasting Blood Glucose, Stress Hyperglycemia Ratio, and Functional Outcomes in Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis
por: Chen, Guangyong, et al.
Publicado: (2022)

Remote ischemic conditioning combined with intravenous thrombolysis for acute ischemic stroke
por: He, Yao‐De, et al.
Publicado: (2020)

Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke
por: Wang, Meng‐Die, et al.
Publicado: (2017)

Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
por: Nam, Ki-Woong, et al.
Publicado: (2017)

Serum amyloid A is a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis
por: Chang, Qi, et al.
Publicado: (2023)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
por: Lee, Bo-Yeon, et al.
Publicado: (2019)

Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012)

Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis
por: Tan, Ge, et al.
Publicado: (2017)

Correlation Between Intracranial Carotid Artery Calcification and Prognosis of Acute Ischemic Stroke After Intravenous Thrombolysis
por: Shen, Yuan, et al.
Publicado: (2022)

Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Zhou, Hongyu, et al.
Publicado: (2020)

Comparison of Different Dosages of Alteplase in Atrial Fibrillation–Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan
por: Lin, Sheng‐Feng, et al.
Publicado: (2022)

Serum 25-hydroxyvitamin D deficiency predicts poor outcomes among acute ischemic stroke patients receiving intravenous thrombolysis
por: Wei, Lei, et al.
Publicado: (2019)

Stroke Code Improves Intravenous Thrombolysis Administration in Acute Ischemic Stroke
por: Chen, Chih-Hao, et al.
Publicado: (2014)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

Clinical Implications of Serial Glucose Measurements in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Kim, Joon-Tae, et al.
Publicado: (2018)

Low versus standard dose intravenous alteplase in the treatment of acute ischemic stroke in Egyptian patients
por: Salem, Gelan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u3o6lngb9560fvmhupgg9qpk8l